Repligen | هزینه بهره بدهی



Interest Expense On Debt تغییر دادن تاریخ
Agilent USD 28M 4M 2025-01
Align Technology 0 0 2024-09
Bio Techne USD 2.15M 28K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Bruker USD 8M 4.8M 2024-12
Charles River Laboratories USD 28.23M 2.05M 2024-12
Danaher USD 61M 26M 2024-12
Dentsply International USD 16M 2M 2024-12
Exact Sciences USD 9.58M 30K 2024-12
General Electric USD 224M 27M 2024-12
Henry Schein USD 35M 1000K 2024-12
Illumina USD 25M 11M 2024-12
IQVIA Holdings USD 171M 1000K 2024-12
Mettler Toledo International USD 17.85M 749K 2024-12
Myriad Genetics USD 700K 100K 2024-12
Patterson Companies USD 10.75M 1.04M 2025-01
Pfizer USD 739M 45M 2024-12
Repligen USD 5.46M 88K 2024-12
Revvity USD 22.78M 1.6M 2024-12
Standard Biotools USD 4.4M 800K 2024-06
Thermo Fisher Scientific USD 316M 40M 2024-12
Waters USD 19M 1.82M 2024-12
West Pharmaceutical Services USD -800000 1.5M 2024-12



Repligen هزینه بهره بدهی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2025.